Skip to main navigation
Skip to search
Skip to main content
University of St Andrews Research Portal Home
Help & FAQ
Link opens in a new tab
Search content at University of St Andrews Research Portal
Home
Profiles
Research output
Datasets
Research units
Equipment
Projects
Activities
Impacts
Prizes
Press/Media
Student theses
Multiple sclerosis and extract of cannabis: results of the MUSEC trial
John Peter Zajicek
, Jeremy C Hobart
, Anita Slade
, David Barnes
, Paul G Mattison
, MUSEC Research Group
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Multiple sclerosis and extract of cannabis: results of the MUSEC trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cannabis
100%
Multiple Sclerosis
100%
Muscle Rigidity
50%
Placebo
50%
Walking Ability
25%
Muscle Spasm
25%
Spasticity
12%
Sleep Quality
12%
Drug Dose Titration
12%
Tetrahydrocannabinol
12%
Rating Scale
12%
Cannabinoid
12%
Side Effect
12%
Oral
12%
Patient-Reported Outcome
12%
Adverse Event
12%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Cannabis
100%
Placebo
50%
Muscle Rigidity
50%
Muscle Spasm
25%
Tetrahydrocannabinol
12%
Adverse Event
12%
Spasticity
12%
Cannabinoid
12%
Side Effect
12%
Neuroscience
Multiple Sclerosis
100%
Cannabis
100%
Placebo
50%
Tetrahydrocannabinol
12%
Sleep Quality
12%
Cannabinoid
12%
Side Effect
12%